Today: 10 June 2026
Browse Category

NYSE:BTE 12 November 2025 - 26 November 2025

Baytex Energy (BTE) Stock Today, November 26, 2025: Eagle Ford Exit Reshapes This Canadian Oil Producer

Baytex Energy (BTE) Stock Today, November 26, 2025: Eagle Ford Exit Reshapes This Canadian Oil Producer

Baytex Energy shares traded near 52-week highs Wednesday as investors weighed the US$2.305 billion Eagle Ford asset sale. On the TSX, Baytex closed at C$4.43, with about 4 million shares traded. No new company announcements were issued. The stock remains about 4% below its annual peak and up roughly 10% year-over-year.
26 November 2025
····
Baytex Energy (BTE.TO) Sells Eagle Ford Assets for US$2.305 Billion; Stock Jumps After CIRO Halt — Nov. 12, 2025

Baytex Energy (BTE.TO) Sells Eagle Ford Assets for US$2.305 Billion; Stock Jumps After CIRO Halt — Nov. 12, 2025

Baytex Energy will sell its entire U.S. Eagle Ford business for US$2.305 billion in cash to an undisclosed buyer. The company plans to repay debt and boost shareholder returns, shifting focus to Canadian oil assets. Trading in Baytex shares was briefly halted before rising on the Toronto Stock Exchange. Deal closing is expected in late 2025 or early 2026, pending approvals.
12 November 2025
·····

Stock Market Today

  • BIO-key Receives Nasdaq Notice for Delayed 10-Q Filing
    June 10, 2026, 5:45 PM EDT. BIO-key International, Inc. (OTC: BKYI) received a non-compliance notice from Nasdaq for failing to file its Quarterly Report on Form 10-Q for Q1 2026 on time as required by Nasdaq Listing Rule 5250(c)(1). Nasdaq's notification states the company's delay could affect its continued listing on the Nasdaq Capital Market pending a Hearing Panel determination. BIO-key specializes in biometric authentication and identity access management (IAM) technologies. The company serves over 40 million users with its cloud-hosted and on-premise PortalGuard IAM solution, supporting secure, multi-factor authentication options including passwordless methods. This regulatory development adds pressure on BIO-key to meet reporting requirements amid its efforts to secure market confidence.

Latest articles

YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Snap Inc. Targets Health Ad Dollars With New Snapchat Study as Pressure Builds

Snap Shares Drop Again With Tech Names Under Pressure

10 June 2026
Snap Inc. shares slid 4% to $5.38, extending a three-day losing streak and deepening doubts about its turnaround despite improved cash flow and cost cuts, as investors await CEO Evan Spiegel’s June 16 AWE keynote and weigh weak ad growth, falling eCPMs, and ongoing macro and regulatory risks.
Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

10 June 2026
Outlook Therapeutics soared 26% to $0.89 on heavy volume as investors zeroed in on the FDA’s 60-day review window for Lytenava after a successful appeal, but risks remain with the stock still under $1, looming Nasdaq compliance deadlines, and warnings of possible dilution and going-concern doubts if FDA approval or favorable labeling isn’t secured soon.
Go toTop